Related references
Note: Only part of the references are listed.Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
Marco Gerlinger et al.
NATURE GENETICS (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
High-precision timeline for Earth's most severe extinction
Seth D. Burgess et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Radiologically Defined Ecological Dynamics and Clinical Outcomes in Glioblastoma Multiforme: Preliminary Results
Mu Zhou et al.
TRANSLATIONAL ONCOLOGY (2014)
Tolerance of Whole-Genome Doubling Propagates Chromosomal Instability and Accelerates Cancer Genome Evolution
Sally M. Dewhurst et al.
CANCER DISCOVERY (2014)
On the Biological Success of Viruses
Brian R. Wasik et al.
ANNUAL REVIEW OF MICROBIOLOGY, VOL 67 (2013)
High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma
Edmund A. Mroz et al.
CANCER (2013)
Single-Molecule Genomic Data Delineate Patient-Specific Tumor Profiles and Cancer Stem Cell Organization
Andrea Sottoriva et al.
CANCER RESEARCH (2013)
A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer
Jordan Berlin et al.
CLINICAL CANCER RESEARCH (2013)
Low-dose metronomic chemotherapy: A systematic literature analysis
K. Lien et al.
EUROPEAN JOURNAL OF CANCER (2013)
Cabozantinib in Patients With Advanced Prostate Cancer: Results of a Phase II Randomized Discontinuation Trial
David C. Smith et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Vascular Endothelial Growth Factor A Promotes Vaccinia Virus Entry into Host Cells via Activation of the Akt Pathway
Crispin T. Hiley et al.
JOURNAL OF VIROLOGY (2013)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers
Steven A. Roberts et al.
NATURE GENETICS (2013)
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
Dereck Amakye et al.
NATURE MEDICINE (2013)
Taxane benefit in breast cancer-a role for grade and chromosomal stability
Roger P. A'Hern et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
How the Red Queen Drives Terrestrial Mammals to Extinction
Tiago B. Quental et al.
SCIENCE (2013)
Zircon U-Pb Geochronology Links the End-Triassic Extinction with the Central Atlantic Magmatic Province
Terrence J. Blackburn et al.
SCIENCE (2013)
Oncolytic and Immunotherapeutic Vaccinia Induces Antibody-Mediated Complement-Dependent Cancer Cell Lysis in Humans
Mi Kyung Kim et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
NSAIDs Modulate Clonal Evolution in Barrett's Esophagus
Rumen L. Kostadinov et al.
PLOS GENETICS (2013)
Life history trade-offs in cancer evolution
C. Athena Aktipis et al.
NATURE REVIEWS CANCER (2013)
The mechanism of background extinction
Delbert Wiens et al.
BIOLOGICAL JOURNAL OF THE LINNEAN SOCIETY (2012)
Dispersal Evolution in Neoplasms: The Role of Disregulated Metabolism in the Evolution of Cell Motility
C. Athena Aktipis et al.
CANCER PREVENTION RESEARCH (2012)
Intratumor Heterogeneity: Evolution through Space and Time
Charles Swanton
CANCER RESEARCH (2012)
Disrupting the Networks of Cancer
Daniel F. Camacho et al.
CLINICAL CANCER RESEARCH (2012)
A Phase II, Randomized, Placebo-Controlled Study of Vismodegib as Maintenance Therapy in Patients with Ovarian Cancer in Second or Third Complete Remission
Stanley B. Kaye et al.
CLINICAL CANCER RESEARCH (2012)
A Novel Therapeutic Regimen to Eradicate Established Solid Tumors with an Effective Induction of Tumor-Specific Immunity
James R. Tysome et al.
CLINICAL CANCER RESEARCH (2012)
Molecular Pathways: Targeting Hsp90-Who Benefits and Who Does Not
Maurizio Scaltriti et al.
CLINICAL CANCER RESEARCH (2012)
3 '-Deoxy-3 '-F-18-Fluorothymidine PET and MRI for Early Survival Predictions in Patients with Recurrent Malignant Glioma Treated with Bevacizumab
Johannes Schwarzenberg et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Genome-wide RNA interference analysis of renal carcinoma survival regulators identifies MCT4 as a Warburg effect metabolic target
Marco Gerlinger et al.
JOURNAL OF PATHOLOGY (2012)
Systemic Buffers Inhibit Carcinogenesis in TRAMP Mice
Arig Ibrahim-Hashim et al.
JOURNAL OF UROLOGY (2012)
Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy
Martina Kleber et al.
LEUKEMIA & LYMPHOMA (2012)
Therapeutic targets in cancer cell metabolism and autophagy
Heesun Cheong et al.
NATURE BIOTECHNOLOGY (2012)
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Marco Gerlinger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Cancer treatment as a game: integrating evolutionary game theory into the optimal control of chemotherapy
Paul A. Orlando et al.
PHYSICAL BIOLOGY (2012)
Antiangiogenic Therapy for Cancer: An Update
Belal Al-Husein et al.
PHARMACOTHERAPY (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
Mark S. Ferguson et al.
ADVANCES IN VIROLOGY (2012)
Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
Rebecca Roylance et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Paradoxical Relationship between Chromosomal Instability and Survival Outcome in Cancer
Nicolai J. Birkbak et al.
CANCER RESEARCH (2011)
The emerging role of viruses in the treatment of solid tumours
M. G. Bourke et al.
CANCER TREATMENT REVIEWS (2011)
Evolutionary Dynamics in Cancer Therapy
Jessica J. Cunningham et al.
MOLECULAR PHARMACEUTICS (2011)
Genetic variegation of clonal architecture and propagating cells in leukaemia
Kristina Anderson et al.
NATURE (2011)
Tumour evolution inferred by single-cell sequencing
Nicholas Navin et al.
NATURE (2011)
Has the Earth's sixth mass extinction already arrived?
Anthony D. Barnosky et al.
NATURE (2011)
Antiangiogenic therapy, hypoxia, and metastasis: risky liaisons, or not?
Katrien De Bock et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Solving the Puzzle of Metastasis: The Evolution of Cell Migration in Neoplasms
Jun Chen et al.
PLOS ONE (2011)
Calibrating the End-Permian Mass Extinction
Shu-zhong Shen et al.
SCIENCE (2011)
The Use of Volumetric CT as an Imaging Biomarker in Lung Cancer
Andrew J. Buckler et al.
ACADEMIC RADIOLOGY (2010)
A theoretical quantitative model for evolution of cancer chemotherapy resistance
Ariosto S. Silva et al.
BIOLOGY DIRECT (2010)
A Comprehensive Survey of Clonal Diversity Measures in Barrett's Esophagus as Biomarkers of Progression to Esophageal Adenocarcinoma
Lauren M. F. Merlo et al.
CANCER PREVENTION RESEARCH (2010)
Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck
Kevin J. Harrington et al.
CLINICAL CANCER RESEARCH (2010)
International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured?
Olivia Pagani et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study
Rolf D. Issels et al.
LANCET ONCOLOGY (2010)
Metronomic chemotherapy: new rationale for new directions
Eddy Pasquier et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The Chicxulub Asteroid Impact and Mass Extinction at the Cretaceous-Paleogene Boundary
Peter Schulte et al.
SCIENCE (2010)
The Epidermal Growth Factor Receptor (EGFR) Promotes Uptake of Influenza A Viruses (IAV) into Host Cells
Thorsten Eierhoff et al.
PLOS PATHOGENS (2010)
Bacteria in cancer therapy: a novel experimental strategy
S. Patyar et al.
JOURNAL OF BIOMEDICAL SCIENCE (2010)
Lower Extinction Risk in Sleep-or-Hide Mammals
Lee Hsiang Liow et al.
AMERICAN NATURALIST (2009)
Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
Janine T. Erler et al.
CANCER CELL (2009)
Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
John M. L. Ebos et al.
CANCER CELL (2009)
Lessons from Applied Ecology: Cancer Control Using an Evolutionary Double Bind
Robert A. Gatenby et al.
CANCER RESEARCH (2009)
METRONOMIC CHEMOTHERAPY. CHANGING THE PARADIGM THAT MORE IS BETTER
O.Graciela Scharovsky et al.
Current Oncology (2009)
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
The sixth mass coextinction: are most endangered species parasites and mutualists?
Robert R. Dunn et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair
Alan Ashworth
JOURNAL OF CLINICAL ONCOLOGY (2008)
CANCER STEM CELLS Here, there, everywhere?
Connie J. Eaves
NATURE (2008)
Efficient tumour formation by single human melanoma cells
Elsa Quintana et al.
NATURE (2008)
Press-pulse: a general theory of mass extinction?
Nan Crystal Arens et al.
PALEOBIOLOGY (2008)
Are we in the midst of the sixth mass extinction? A view from the world of amphibians
David B. Wake et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Ecological Therapy for Cancer: Defining Tumors Using an Ecosystem Paradigm Suggests New Opportunities for Novel Cancer Treatments
Kenneth J. Pienta et al.
TRANSLATIONAL ONCOLOGY (2008)
Mechanisms of disease: epithelial-mesenchymal transition - does cellular plasticity fuel neoplastic progression?
Eva A. Turley et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Matrix metalloproteinases-1 and -8 improve the distribution and efficacy of an oncolytic virus
Wison Mok et al.
CANCER RESEARCH (2007)
The evolutionary consequences of polyploidy
Sarah P. Otto
CELL (2007)
Actual 10-year survival after resection of colorectal liver Metastases defines cure
James S. Tomlinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The effect of geographic range on extinction risk during background and mass extinction
Jonathan L. Payne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Paleophysiology and end-Permian mass extinction
Andrew H. Knoll et al.
EARTH AND PLANETARY SCIENCE LETTERS (2007)
Increased genetic variation and evolutionary potential drive the success of an invasive grass
Sebastien Lavergne et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Metabolic catastrophe as a means to cancer cell death
Shengkan Jin et al.
JOURNAL OF CELL SCIENCE (2007)
Glycolysis in cancer: A potential target for therapy
Robert A. Gatenby et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Cancer as an evolutionary and ecological process
Lauren M. F. Merlo et al.
NATURE REVIEWS CANCER (2006)
Opinion -: Invasive growth:: a MET-driven genetic programme for cancer and stem cells
Carla Boccaccio et al.
NATURE REVIEWS CANCER (2006)
Genetic clonal diversity predicts progression to esophageal adenocarcinoma
CC Maley et al.
NATURE GENETICS (2006)
Mesenchymal progenitor cells as cellular vehicles for delivery of oncolytic adenoviruses
S Komarova et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Progress and review of the studies on the end-Triassic Mass extinction event
SH Deng et al.
SCIENCE IN CHINA SERIES D-EARTH SCIENCES (2005)
Tumor immunity: a balancing act between T cell activation, macrophage activation and tumor-induced immune suppression
P Sinha et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Randomized trial of hyperthermia and radiation for superficial tumors
EL Jones et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The concept of synthetic lethality in the context of anticancer therapy
WG Kaelin
NATURE REVIEWS CANCER (2005)
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients
TL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Extinction risk from climate change
CD Thomas et al.
NATURE (2004)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Retroviral restriction by APOBEC proteins
RS Harris et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Why do cancers have high aerobic glycolysis?
RA Gatenby et al.
NATURE REVIEWS CANCER (2004)
The anti-angiogenic basis of metronomic chemotherapy
RS Kerbel et al.
NATURE REVIEWS CANCER (2004)
Assessing the causes of Late Pleistocene extinctions on the continents
AD Barnosky et al.
SCIENCE (2004)
Survival in the first hours of the Cenozoic
DS Robertson et al.
GEOLOGICAL SOCIETY OF AMERICA BULLETIN (2004)
Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial
J Overgaard et al.
LANCET (2003)
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
HD Dong et al.
NATURE MEDICINE (2002)
The cellular and molecular basis of hyperthermia
B Hildebrandt et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Anatomical and ecological constraints on Phanerozoic animal diversity in the marine realm
RK Bambach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Cancer therapy - Matrix metalloproteinase inhibitors and cancer: Trials and tribulations
LM Coussens et al.
SCIENCE (2002)
New functions for the matrix metalloproteinases in cancer progression
M Egeblad et al.
NATURE REVIEWS CANCER (2002)
Combination bacteriolytic therapy for the treatment of experimental tumors
LH Dang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Late Frasnian-Famennian climates based on palynomorph analyses and the question of the Late Devonian glaciations
M Streel et al.
EARTH-SCIENCE REVIEWS (2000)
Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours:: a prospective, randomised, multicentre trial
J van der Zee et al.
LANCET (2000)
Share Paper
